TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.

Yutaka Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.